fashion -WSS

fashion

author：focus 2025-09-29 22:38:09 - browse：2

Sen. Bob Menendez (D-N.J.) Michael M. Santiago/Getty Images

WASHINGTON — With mounting calls for embattled Sen. Bob Menendez to resign, the pharmaceutical industry could see one of its historical, and increasingly rare, Democratic allies ousted from Congress.

The New Jersey senator is embroiled in another financial scandal after last week’s indictment over hundreds of thousands of dollars he and his wife allegedly accepted to influence military aid. The charges — which Menendez insists he will beat — come roughly seven years after he was accused of pressuring Medicare officials to resolve a dispute in favor of a lavish political donor. That case ended in a hung jury.

But this time around, Capitol lawmakers and New Jersey Democrats including Sen. Cory Booker, a longtime legislation partner, are calling on Menendez to resign. The mounting pressure and looming court battle spell out a hazy future for one of the pharmaceutical industry’s biggest allies in the Democratic Party.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Readout LOUD podcast, live from the STAT Breakthrough Summit East

hotspot

Wikipedia

WSS

Idaho college killings prosecutors challenge defense's grand jury claims

Aspartame and sugar

After Optum profits sink, UnitedHealth makes changes

YouTube cracks down on misinformation on cancer treatment

YouTube cracks down on misinformation on cancer treatment

Medical devices makers are asking for forgiveness, not permission

hotspot

fashion

hotspot

How one medical school became remarkably diverse

What to know about the judge who will handle the Trump case

DIEP, the 'gold standard' of breast reconstruction, is under threat

Pfizer, Moderna say biotech, pharma drug development is a sprint

How one medical school became remarkably diverse

Illumina slashes 2023 revenue projections yet again

Drug repurposing or repositioning? The language matters

Be careful with at

Medical leaders decry Supreme Court decision on affirmative action

Biogen’s boardroom scandal saddles CEO with first crisis

hotspot

Bird flu researchers hone in on Finland’s mink farms

Medical devices makers are asking for forgiveness, not permission

Yancopoulos of Regeneron works to expand Dupixent success

Readout LOUD podcast, live from the STAT Breakthrough Summit East

U.K. officials, researchers try to ease path for bespoke genetic treatments

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

focus

hotspot

Wikipedia

entertainment